Financial Results : SPIMACO turns to SAR 45.6 mln profit in Q1 2020

SPIMACO turns to SAR 45.6 mln profit in Q1 2020

17/06/2020 Argaam Exclusive

View other reports

Saudi Pharmaceutical Industries and Medical Appliances Corp. (SPIMACO) reported a net profit after Zakat and tax of SAR 45.6 million for Q1 2020, against a net loss of SAR 21.6 million a year earlier.



Current Quarter Comparison (M)

Compared With The
Item Q1 2019 Q1 2020 Change‬
Revenues 444.80 475.72 7.0 %
Gross Income 152.43 198.73 30.4 %
Operating Income 16.97 57.44 238.5 %
Net Income (21.71) 45.60 310.1 %
Average Shares 120.00 120.00 -
EPS (Riyals) (0.18) 0.38 310.1 %

The positive performance was driven by a 7.78% rise year-on-year in revenue, a decline in the cost of goods sold amid better sales mix, an increase in produced units and lower production costs.

 

The company turned profitable from a net loss of SAR 303.3 million in Q4 2019, backed by a decline in the cost of goods sold amid better sales mix, an increase in produced units and lower production costs.

 

SPIMACO’s accumulated losses stood at SAR 246.29 million by the end of Q1 2020, accounting for 20.52% of capital.

Kindly, you can view the full report by subscribing to the

The report contains the details of the financial statements, The most important financial indicators, Historical information, Charts, and Forecasts of experts.

Contact Us (+966)-92000-7759

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.